Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-04-09 @ 7:19 AM
Study NCT ID:
NCT01110902
Status:
COMPLETED
Last Update Posted:
2020-12-24
First Post:
2010-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-05
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-23
First Submit QC Date:
None
Study First Post Date:
2010-04-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-08-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2020-12-24
Last Update Post Date Type:
ACTUAL